Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emiliano Roselli

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Investigation|January 19, 2021
Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomesEmiliano Roselli, Rawan Faramand, Marco L Davila
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 26, 2019
CAR-T Engineering: Optimizing Signal Transduction and Effector MechanismsEmiliano Roselli, Jeremy S Frieling, Konrad Thorner, et al.
Frontiers in Immunology|November 30, 2019
Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell ActivationMaría Julia Lamberti, Fátima María Mentucci, Emiliano Roselli, et al.
Frontiers in Immunology|April 6, 2019
TLR3 Activation of Intratumoral CD103<sup>+</sup> Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor ImmunityEmiliano Roselli, Paula Araya, Nicolás Gonzalo Núñez, et al.
Plos One|June 30, 2017
Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanomaLucas Daniel Trucco, Emiliano Roselli, Paula Araya, et al.
Plos One|October 17, 2015
Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 LigandEstefanía R Zacca, María I Crespo, Rachel P Acland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2016
In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid AdministrationDavid Andrés Nocera, Emiliano Roselli, Paula Araya, et al.
Breast Cancer Research : BCR|March 26, 2021
High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancerGerardo Gatti, Courtney Betts, Darío Rocha, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2019
Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivityPaula Araya, Katherine A Waugh, Kelly D Sullivan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Investigation|January 19, 2021
Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomesEmiliano Roselli, Rawan Faramand, Marco L Davila
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 26, 2019
CAR-T Engineering: Optimizing Signal Transduction and Effector MechanismsEmiliano Roselli, Jeremy S Frieling, Konrad Thorner, et al.
Frontiers in Immunology|November 30, 2019
Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell ActivationMaría Julia Lamberti, Fátima María Mentucci, Emiliano Roselli, et al.
Frontiers in Immunology|April 6, 2019
TLR3 Activation of Intratumoral CD103<sup>+</sup> Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor ImmunityEmiliano Roselli, Paula Araya, Nicolás Gonzalo Núñez, et al.
Plos One|June 30, 2017
Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanomaLucas Daniel Trucco, Emiliano Roselli, Paula Araya, et al.
Plos One|October 17, 2015
Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 LigandEstefanía R Zacca, María I Crespo, Rachel P Acland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 17, 2016
In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid AdministrationDavid Andrés Nocera, Emiliano Roselli, Paula Araya, et al.
Breast Cancer Research : BCR|March 26, 2021
High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancerGerardo Gatti, Courtney Betts, Darío Rocha, et al.
Journal for Immunotherapy of Cancer|October 28, 2021
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cellsEmiliano Roselli, Justin C Boucher, Gongbo Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2019
Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivityPaula Araya, Katherine A Waugh, Kelly D Sullivan, et al.
Pageof 2